DCM Shriram Fine

Which are the latest news on DCM Shriram Fine?

Why is DCM Shriram Fine Chemicals Ltd falling/rising?

As of 05-Sep, DCM Shriram Fine Chemicals Ltd is experiencing a decline in its stock price, currently at 25.67, reflecting a total decline of -2.4% over the last two days and -5.90% over the past week, significantly underperforming the benchmark Sensex. Despite increased investor participation, the stock's performance remains mixed, with it underperforming its sector by 0.5%.

As of 05-Sep, DCM Shriram Fine Chemicals Ltd is experiencing a decline in its stock price, currently at 25.67, which reflects a change of -0.06 or -0.23%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of -2.4% during this period. Additionally, over the past week, the stock has decreased by 5.90%, while the benchmark Sensex has only dropped by 0.97%, indicating a significant underperformance relative to the market.<BR><BR>In terms of moving averages, the stock is currently higher than the 50-day and 100-day moving averages but lower than the 5-day, 20-day, and 200-day moving averages, suggesting a mixed performance trend. Furthermore, despite a rise in investor participation, with delivery volume increasing by 111.19% against the 5-day average, the overall performance today indicates that the stock has underperformed its sector by 0.5%. <BR><BR>These factors collectively contribute to the downward movement in the stock price of DCM Shriram Fine Chemicals Ltd.

What does DCM Shriram Fine do?

DCM Shriram Fine Chemicals Ltd is a micro-cap company in the commodity chemicals industry, incorporated in September 2021, with net sales of 91 Cr and a net profit of 3 Cr as of June 2026. It has a market cap of INR 235 Cr and key metrics include a dividend yield of 1.47% and a debt-equity ratio of -0.21.

Overview:<BR>DCM Shriram Fine Chemicals Ltd operates in the commodity chemicals industry and is classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated on September 29, 2021, as a Public Limited Company, with a Certificate of Incorporation issued on September 30, 2021. Prior to this, it was a wholly owned subsidiary of DCM Shriram Industries Limited. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 91 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 3 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 235 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 43 <BR>Dividend Yield: 1.47% <BR>Debt-Equity: -0.21 <BR>Return on Equity: -2.15% <BR>Price to Book: 1.18<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the DCM Shriram Fine?

Peers of DCM Shriram Fine include Alufluoride, National Perox., Andhra Petrochem, and others, with varying management risks and growth prospects. Genus Prime leads in 1-year returns at 72.28%, while ZR2 Bioenergy has the lowest at -70.89%.

Peers: The peers of DCM Shriram Fine are Alufluoride, National Perox., Andhra Petrochem, Genus Prime, Hind.Organ.Chem., IVP, ARCL Organics, ZR2 Bioenergy, Kanchi Karpooram, and Kesar Petroprod.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alufluoride and ARCL Organics, while Good management risk is found at the rest. Average management risk is noted for Andhra Petrochem and IVP, while Below Average management risk is identified at National Perox., Genus Prime, Hind.Organ.Chem., ZR2 Bioenergy, Kesar Petroprod., and the rest. Growth is Good for Alufluoride, Genus Prime, ARCL Organics, and Kanchi Karpooram, while Below Average growth is seen at National Perox., Andhra Petrochem, Hind.Organ.Chem., IVP, ZR2 Bioenergy, and Kesar Petroprod. Average growth is noted for Kanchi Karpooram. Capital Structure is Excellent for National Perox. and Kanchi Karpooram, Good for Alufluoride, Andhra Petrochem, ARCL Organics, and the rest, while Below Average capital structure is found at Genus Prime, Hind.Organ.Chem., IVP, ZR2 Bioenergy, and Kesar Petroprod.<BR><BR>Return Snapshot: Genus Prime has the highest 1-year return at 72.28%, while ZR2 Bioenergy has the lowest at -70.89%. DCM Shriram Fine's 1-year return is not available for comparison. Additionally, the six-month return is negative for DCM Shriram Fine, ZR2 Bioenergy, and Kesar Petroprod.

How big is DCM Shriram Fine?

As of 31st August, DCM Shriram Fine Chemicals Ltd has a market capitalization of 235.00 Cr and reported net sales of 377.71 Cr, with a net loss of 5.26 Cr in the latest four quarters.

As of 31st August, DCM Shriram Fine Chemicals Ltd has a market capitalization of 235.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported net sales of 377.71 Cr. However, it experienced a loss of 5.26 Cr in net profit during the same period.<BR><BR>The latest reporting period for the balance sheet is March 2026, with shareholder's funds amounting to 211.00 Cr and total assets valued at 295.40 Cr.

Should I buy, sell or hold DCM Shriram Fine Chemicals Ltd?

When is the next results date for DCM Shriram Fine Chemicals Ltd?

The next results date for DCM Shriram Fine Chemicals Ltd is 14 August 2026.

The next results date for DCM Shriram Fine Chemicals Ltd is scheduled for 14 August 2026.

Are DCM Shriram Fine Chemicals Ltd latest results good or bad?

DCM Shriram Fine Chemicals Ltd's latest results are concerning, showing a net loss of ₹3.83 crore in Q4 FY26, marking a 260.25% decline year-on-year. The company has faced three consecutive quarters of losses, negative operating margins, and a return on equity of -2.14%, indicating significant operational challenges and a negative outlook.

The latest results for DCM Shriram Fine Chemicals Ltd are concerning and indicate a significant decline in financial performance. In Q4 FY26, the company reported a net loss of ₹3.83 crore, which is a drastic drop of 260.25% year-on-year. This marks the third consecutive quarter of losses, with the losses widening compared to the previous quarter.<BR><BR>Operating margins have also deteriorated sharply, turning negative at -2.71%, down from a positive 6.78% in the same quarter last year. This reflects severe operational challenges, as the company is unable to cover its basic operating expenses from its core business activities. Additionally, net sales fell slightly by 0.29% year-on-year to ₹93.08 crore, but this decline masks deeper issues within the company's operations.<BR><BR>The return on equity has collapsed to -2.14%, indicating that the company is not generating returns for its shareholders. Overall, the financial performance suggests that DCM Shriram Fine Chemicals is facing an operational crisis, raising serious concerns about its viability moving forward. Given these results, the outlook appears quite negative.